IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology
Coronary Wave Intensity Analysis as an Invasive and Vessel-Specific Index of Myocardial Viability | Circulation: Cardiovascular Interventions
Toxics | Free Full-Text | Perinatal Lead Exposure Promotes Sex-Specific Epigenetic Programming of Disease-Relevant Pathways in Mouse Heart
Henrik Eriksson on LinkedIn: #greatresignation #greatrenegotiation
Abhishek Sharma, MD *Maimonides Medical Center 1016 50th Street, Apt. 2C Brooklyn, New York 11219 E-mail: abhisheksharma4mamc@g
Frontiers | Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
Frontiers | Undiagnosed Impaired Glucose Tolerance and Type-2 Diabetes in Acute Myocardial Infarction Patients: Fequency, Characteristics and Long-Term Mortality
Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD
Frontiers | Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury
Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study | PLOS ONE
Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis | Arteriosclerosis, Thrombosis, and Vascular Biology
IJMS | Free Full-Text | Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Hospital Insulin Protocol Aims For Glucose Control In Glucocorticoid-Induced Hyperglycemia - Endocrine Practice
FUBUKI | Stockholm
Untitled
Ramberättelse AN
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes
Diagnostics | Free Full-Text | Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients
Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications | Physiological Reviews
SAS Nordic
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink
JCM | Free Full-Text | The Link between Stroke Risk and Orodental Status—A Comprehensive Review
Optimization Of Insulin Therapy In Patients With Type 2 Diabetes - Endocrine Practice
